Tempus AI, Inc. (NASDAQ:TEM) is one of the stocks Jim Cramer looked at recently. When a caller asked if the stock is a buy, sell, or hold, Cramer said: Well, you know we’re not recommending stocks ...

Tem raised $75 million to expand its AI-based energy transaction platform. The company plans launches in Texas and Australia after UK growth. Its AI engine removes costs and improves pricing for more ...

The funding round was led by Lightspeed Venture Partners and is understood to value the four-year-old company at around $300 million. Tem plans to use the capital to further develop its technology and ...

As AI data centers drive up electricity prices, London-based startup Tem thinks AI might be able to help solve it, too. Tem has built an energy transaction engine that relies on AI to cut prices ...

Beam-sensitive zeolites are difficult to study at high resolution because traditional electron microscopy often damages or destroys their delicate crystal structures before meaningful data can be ...

Tempus AI remains a resilient healthcare AI leader, with proprietary data driving traction and a clear buy opportunity amid recent volatility. TEM reported preliminary 2025 revenue of ~$1.27B (+30% ...

Tempus AI remains a Buy after a market-driven correction, with operational performance and partnerships strengthening the long-term thesis. TEM's organic revenue grew 28% y/y, gross margins improved ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Fintel reports that on December 2, 2025, Morgan Stanley maintained coverage of Tempus AI (NasdaqGS:TEM) with a Overweight recommendation. Analyst Price Forecast Suggests 24.42% Upside As of November ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the best digital health stocks to buy now. Wall Street sentiment toward Tempus AI strengthened on November 5, 2025, following the company's Q3 results, with ...